Page last updated: 2024-10-16

choline and Insulin Resistance

choline has been researched along with Insulin Resistance in 22 studies

Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.

Research Excerpts

ExcerptRelevanceReference
"We investigated the relationships between serum choline and betaine levels with metabolic syndrome-related indices in the general population of Newfoundland."7.91Low serum choline and high serum betaine levels are associated with favorable components of metabolic syndrome in Newfoundland population. ( Gao, X; Randell, E; Sun, G; Tian, Y; Zhou, H, 2019)
"Dietary betaine supplement could ameliorate insulin resistance (IR) in animals, but no data are available for choline."7.85High dietary choline and betaine intake is associated with low insulin resistance in the Newfoundland population. ( Gao, X; Sun, G; Wang, Y, 2017)
"Our findings underscore the importance of changes in TMAO, choline and L-carnitine in improving insulin sensitivity during a weight-loss intervention for obese patients."5.30Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial. ( Bray, GA; DiDonato, JA; Heianza, Y; Li, X; Qi, L; Sacks, FM; Sun, D, 2019)
" The mechanisms underlying gut microbiota-mediated development of NAFLD include modulation of host energy metabolism, insulin sensitivity, and bile acid and choline metabolism."4.98Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota. ( Han, R; Li, H; Ma, J, 2018)
"In general, increasing dietary choline and betaine along with moderate and high physical activity improved insulin resistance, increased HDL, and lowered FBS in the higher tertiles of dietary choline and betaine."4.31The interactive relationship of dietary choline and betaine with physical activity on circulating creatine kinase (CK), metabolic and glycemic markers, and anthropometric characteristics in physically active young individuals. ( Ardekani, AM; Farhangi, MA; Fayyazishishavan, E; Soleimani, E, 2023)
"Trimethylamine N-oxide (TMAO), choline and betaine serum levels have been associated with metabolic diseases including type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD)."4.02Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes. ( Aguilar-Salinas, C; Campos-Pérez, F; Canizales-Quinteros, S; Gómez-Pérez, F; González-González, I; Grandini-Rosales, P; Hazen, SL; Hernández-Pando, R; Huertas-Vazquez, A; Hui, ST; Larrieta-Carrasco, E; León-Mimila, P; Li, XS; López-Contreras, B; Lusis, AJ; Macías-Kauffer, L; Morán-Ramos, S; Ocampo-Medina, E; Olivares-Arevalo, M; Shih, DM; Villamil-Ramírez, H; Villarreal-Molina, T; Wang, Z, 2021)
"We investigated the relationships between serum choline and betaine levels with metabolic syndrome-related indices in the general population of Newfoundland."3.91Low serum choline and high serum betaine levels are associated with favorable components of metabolic syndrome in Newfoundland population. ( Gao, X; Randell, E; Sun, G; Tian, Y; Zhou, H, 2019)
"Dietary betaine supplement could ameliorate insulin resistance (IR) in animals, but no data are available for choline."3.85High dietary choline and betaine intake is associated with low insulin resistance in the Newfoundland population. ( Gao, X; Sun, G; Wang, Y, 2017)
"Ecological evidence suggests that niacin (nicotinamide and nicotinic acid) fortification may be involved in the increased prevalence of obesity and type 2 diabetes, both of which are associated with insulin resistance and epigenetic changes."3.79Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats. ( Cao, JM; Cao, Y; Gong, XJ; Guo, J; Guo, M; Li, D; Lun, YZ; Luo, N; Sun, WP; Tian, YJ; Zhou, SS, 2013)
" The present results suggest that the coupling of high levels of choline and low levels of methionine plays an important role in the development of insulin resistance and liver steatosis."3.77Alterations in hepatic one-carbon metabolism and related pathways following a high-fat dietary intervention. ( Bachmair, EM; Boekschoten, MV; Brennan, L; Coort, SL; Daniel, H; Evelo, C; Gibney, MJ; Keijer, J; Kleemann, R; McLoughlin, GA; Muller, M; Roos, Bd; Rubio-Aliaga, I; Sailer, M; van Erk, M; van Schothorst, EM, 2011)
"To clarify the causal relationship between insulin resistance and the development of NASH, steatohepatitis was induced in obese diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) and nondiabetic control Long-Evans Tokushima Otsuka (LETO) rats by feeding them a methionine and choline-deficient (MCD) diet."3.74Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. ( Akahori, H; Kaneko, S; Kita, Y; Kurita, S; Matsuzawa, N; Misu, H; Nakanuma, Y; Ota, T; Sakurai, M; Takamura, T; Uno, M; Zen, Y, 2007)
"Hyperleptinaemia plays an important role in hyper-responsiveness to MTX in NASH-cirrhotic rat livers with portal hypertension."1.38Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis. ( Hou, MC; Huang, YT; Lee, FY; Lee, SD; Lin, HC; Tsai, TH; Yang, YY, 2012)

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (4.55)18.2507
2000's1 (4.55)29.6817
2010's13 (59.09)24.3611
2020's7 (31.82)2.80

Authors

AuthorsStudies
Poursalehi, D1
Lotfi, K1
Mirzaei, S1
Asadi, A1
Akhlaghi, M1
Saneei, P1
Soleimani, E1
Ardekani, AM1
Fayyazishishavan, E1
Farhangi, MA1
Andersen, CJ1
Huang, L1
Zhai, F1
Esposito, CP1
Greco, JM1
Zhang, R1
Woodruff, R1
Sloan, A1
Van Dyke, AR1
Yamauchi, A1
Tone, T1
Toledo, A1
Igarashi, K1
Sugimoto, K1
Miyai, H1
Deng, D1
Nakamura, J1
Lim, HS1
Kaku, T1
Hirano, E1
Shindo, T1
León-Mimila, P1
Villamil-Ramírez, H1
Li, XS1
Shih, DM1
Hui, ST1
Ocampo-Medina, E1
López-Contreras, B1
Morán-Ramos, S1
Olivares-Arevalo, M1
Grandini-Rosales, P1
Macías-Kauffer, L1
González-González, I1
Hernández-Pando, R1
Gómez-Pérez, F1
Campos-Pérez, F1
Aguilar-Salinas, C1
Larrieta-Carrasco, E1
Villarreal-Molina, T1
Wang, Z1
Lusis, AJ1
Hazen, SL1
Huertas-Vazquez, A1
Canizales-Quinteros, S1
DiBella, M1
Thomas, MS1
Alyousef, H1
Millar, C1
Blesso, C1
Malysheva, O1
Caudill, MA1
Fernandez, ML1
Suchacki, KJ1
Morton, NM1
Vary, C1
Huesa, C1
Yadav, MC1
Thomas, BJ1
Turban, S1
Bunger, L1
Ball, D1
Barrios-Llerena, ME1
Guntur, AR1
Khavandgar, Z1
Cawthorn, WP1
Ferron, M1
Karsenty, G1
Murshed, M1
Rosen, CJ1
MacRae, VE1
Millán, JL1
Farquharson, C1
Heianza, Y1
Sun, D1
Li, X1
DiDonato, JA1
Bray, GA1
Sacks, FM1
Qi, L1
Han, R1
Ma, J1
Li, H1
Gao, X2
Randell, E1
Tian, Y1
Zhou, H1
Sun, G2
Li, D1
Tian, YJ1
Guo, J1
Sun, WP1
Lun, YZ1
Guo, M1
Luo, N1
Cao, Y1
Cao, JM1
Gong, XJ1
Zhou, SS1
Gautheron, J1
Vucur, M1
Schneider, AT1
Severi, I1
Roderburg, C1
Roy, S1
Bartneck, M1
Schrammen, P1
Diaz, MB1
Ehling, J1
Gremse, F1
Heymann, F1
Koppe, C1
Lammers, T1
Kiessling, F1
Van Best, N1
Pabst, O1
Courtois, G1
Linkermann, A1
Krautwald, S1
Neumann, UP1
Tacke, F1
Trautwein, C1
Green, DR1
Longerich, T1
Frey, N1
Luedde, M1
Bluher, M1
Herzig, S1
Heikenwalder, M1
Luedde, T1
Pandey, S1
Garabadu, D1
Wang, Y1
Jacobs, RL2
Zhao, Y1
Koonen, DP1
Sletten, T1
Su, B1
Lingrell, S1
Cao, G1
Peake, DA1
Kuo, MS1
Proctor, SD1
Kennedy, BP1
Dyck, JR1
Vance, DE2
Rubio-Aliaga, I1
Roos, Bd1
Sailer, M1
McLoughlin, GA1
Boekschoten, MV1
van Erk, M1
Bachmair, EM1
van Schothorst, EM1
Keijer, J1
Coort, SL1
Evelo, C1
Gibney, MJ1
Daniel, H1
Muller, M1
Kleemann, R1
Brennan, L1
Saccà, F1
Quarantelli, M1
Rinaldi, C1
Tucci, T1
Piro, R1
Perrotta, G1
Carotenuto, B1
Marsili, A1
Palma, V1
De Michele, G1
Brunetti, A1
Brescia Morra, V1
Filla, A1
Salvatore, M1
Yang, YY1
Huang, YT1
Tsai, TH1
Hou, MC1
Lee, FY1
Lee, SD1
Lin, HC1
Zeisel, SH1
Wu, G1
Zhang, L1
Li, T1
Zuniga, A1
Lopaschuk, GD1
Li, L1
Ota, T1
Takamura, T1
Kurita, S1
Matsuzawa, N1
Kita, Y1
Uno, M1
Akahori, H1
Misu, H1
Sakurai, M1
Zen, Y1
Nakanuma, Y1
Kaneko, S1
Long, SD1
Pekala, PH1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Preventing Overweight Using Novel Dietary Strategies (Pounds Lost)[NCT00072995]811 participants Interventional2003-09-30Completed
A Patient Centric Motor Neuron Disease Activities of Daily Living Scale[NCT02852278]410 participants (Actual)Observational2016-12-31Completed
Effects of Choline Supplementation on Fetal Growth in Gestational Diabetes Mellitus[NCT04302168]60 participants (Anticipated)Interventional2020-04-01Recruiting
FRUVEDomics Study: Use of a Behavioral Nutrition Intervention in Young Adults to Identify Modifiable Metabolomics and Microbiome Risk[NCT03115866]53 participants (Actual)Interventional2015-01-15Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for choline and Insulin Resistance

ArticleYear
Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota.
    Frontiers of medicine, 2018, Volume: 12, Issue:6

    Topics: Animals; Bile Acids and Salts; Choline; Dietary Supplements; Energy Metabolism; Fecal Microbiota Tra

2018
Metabolic crosstalk between choline/1-carbon metabolism and energy homeostasis.
    Clinical chemistry and laboratory medicine, 2013, Mar-01, Volume: 51, Issue:3

    Topics: Animals; Betaine; Carbon; Choline; Energy Metabolism; Humans; Insulin Resistance; Metabolic Networks

2013

Trials

4 trials available for choline and Insulin Resistance

ArticleYear
Consumption of Different Egg-Based Diets Alters Clinical Metabolic and Hematological Parameters in Young, Healthy Men and Women.
    Nutrients, 2023, Aug-27, Volume: 15, Issue:17

    Topics: Adult; Cholesterol; Choline; Diet; Female; Humans; Insulin Resistance; Lipid Metabolism; Male

2023
Choline Intake as Supplement or as a Component of Eggs Increases Plasma Choline and Reduces Interleukin-6 without Modifying Plasma Cholesterol in Participants with Metabolic Syndrome.
    Nutrients, 2020, Oct-13, Volume: 12, Issue:10

    Topics: Adult; Aged; Cholesterol, LDL; Choline; Cross-Over Studies; Dietary Supplements; Eating; Eggs; Femal

2020
Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial.
    Gut, 2019, Volume: 68, Issue:2

    Topics: Adult; Amino Acids; Carnitine; Choline; Diet, Reducing; Female; Gastrointestinal Microbiome; Glucose

2019
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results.
    Journal of neurology, 2012, Volume: 259, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Arginine; Choline; Creatine; Double-B

2012

Other Studies

16 other studies available for choline and Insulin Resistance

ArticleYear
Association between methyl donor nutrients and metabolic health status in overweight and obese adolescents.
    Scientific reports, 2022, 10-11, Volume: 12, Issue:1

    Topics: Adolescent; Betaine; Body Mass Index; Choline; Cross-Sectional Studies; Female; Health Status; Human

2022
The interactive relationship of dietary choline and betaine with physical activity on circulating creatine kinase (CK), metabolic and glycemic markers, and anthropometric characteristics in physically active young individuals.
    BMC endocrine disorders, 2023, Jul-25, Volume: 23, Issue:1

    Topics: Adolescent; Betaine; Choline; Cross-Sectional Studies; Diet; Exercise; Humans; Insulin Resistance; U

2023
Placental extract ameliorates liver fibrosis in a methionine- and choline-deficient diet-induced mouse model of non-alcoholic steatohepatitis.
    Biomedical research (Tokyo, Japan), 2020, Volume: 41, Issue:1

    Topics: Animal Feed; Animals; Body Weight; Choline; Diet; Disease Models, Animal; Female; Hepatic Stellate C

2020
Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes.
    Diabetes & metabolism, 2021, Volume: 47, Issue:2

    Topics: Adult; Betaine; Bile Acids and Salts; Biomarkers; Biopsy; Choline; Diabetes Mellitus, Type 2; Female

2021
PHOSPHO1 is a skeletal regulator of insulin resistance and obesity.
    BMC biology, 2020, 10-22, Volume: 18, Issue:1

    Topics: Animals; Choline; Energy Metabolism; Glucose; Homeostasis; Insulin Resistance; Male; Mice; Obesity;

2020
Low serum choline and high serum betaine levels are associated with favorable components of metabolic syndrome in Newfoundland population.
    Journal of diabetes and its complications, 2019, Volume: 33, Issue:10

    Topics: Adult; Betaine; Blood Glucose; Blood Pressure; Choline; Female; Humans; Insulin Resistance; Lipids;

2019
Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats.
    The British journal of nutrition, 2013, Volume: 110, Issue:12

    Topics: Animals; Betaine; Choline; CpG Islands; Dietary Supplements; DNA; DNA Damage; DNA Methylation; Epige

2013
The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance.
    Nature communications, 2016, 06-21, Volume: 7

    Topics: Adipocytes; Adipose Tissue, White; Animals; Apoptosis; Body Mass Index; Caspase 8; Choline; Choline

2016
Piracetam Facilitates the Anti-Amnesic but not Anti-Diabetic Activity of Metformin in Experimentally Induced Type-2 Diabetic Encephalopathic Rats.
    Cellular and molecular neurobiology, 2017, Volume: 37, Issue:5

    Topics: Amnesia; Animals; Blood Glucose; Brain Diseases; Brain-Derived Neurotrophic Factor; Choline; Diabete

2017
High dietary choline and betaine intake is associated with low insulin resistance in the Newfoundland population.
    Nutrition (Burbank, Los Angeles County, Calif.), 2017, Volume: 33

    Topics: Adult; Betaine; Blood Glucose; Choline; Diet; Diet Surveys; Fasting; Feeding Behavior; Female; Human

2017
Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity.
    The Journal of biological chemistry, 2010, Jul-16, Volume: 285, Issue:29

    Topics: Animals; Betaine; Choline; Diet; Dietary Fats; Dietary Supplements; Energy Metabolism; Fatty Liver;

2010
Alterations in hepatic one-carbon metabolism and related pathways following a high-fat dietary intervention.
    Physiological genomics, 2011, Apr-27, Volume: 43, Issue:8

    Topics: Animals; Blood Glucose; Carbon; Cholesterol; Choline; Dietary Fats; Fatty Liver; Hyperglycemia; Insu

2011
Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis.
    Clinical science (London, England : 1979), 2012, Volume: 123, Issue:12

    Topics: Analysis of Variance; Animals; Arachidonic Acid; Benzofurans; Choline; Clodronic Acid; Diet, High-Fa

2012
Choline supplementation promotes hepatic insulin resistance in phosphatidylethanolamine N-methyltransferase-deficient mice via increased glucagon action.
    The Journal of biological chemistry, 2013, Jan-11, Volume: 288, Issue:2

    Topics: Animals; Base Sequence; Choline; DNA Primers; Glucagon; Gluconeogenesis; Glucose Tolerance Test; Ins

2013
Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Gastroenterology, 2007, Volume: 132, Issue:1

    Topics: Animal Feed; Animals; Choline; Collagen Type I; Collagen Type I, alpha 1 Chain; Diabetes Mellitus, T

2007
Lipid mediators of insulin resistance: ceramide signalling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes.
    The Biochemical journal, 1996, Oct-01, Volume: 319 ( Pt 1)

    Topics: 3T3 Cells; 5,8,11,14-Eicosatetraynoic Acid; Adipose Tissue; Animals; Arachidonic Acid; Ceramides; Ch

1996